| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 1.694 | 0 | 5.855 | 16.557 | 1.126 | 0 |
| Total Income - EUR | - | - | - | - | 1.694 | 1.377 | 30.293 | 16.557 | 40.172 | 0 |
| Total Expenses - EUR | - | - | - | - | 0 | 10.676 | 27.368 | 27.624 | 7.016 | 4.017 |
| Gross Profit/Loss - EUR | - | - | - | - | 1.694 | -9.299 | 2.926 | -11.067 | 33.156 | -4.017 |
| Net Profit/Loss - EUR | - | - | - | - | 1.643 | -9.299 | 2.623 | -11.232 | 33.156 | -4.017 |
| Employees | - | - | - | - | 0 | 4 | 4 | 4 | 0 | 0 |
Check the financial reports for the company - Epil Medica S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 0 | 39.929 | 35.004 | 31.062 | 26.928 | 22.761 |
| Current Assets | - | - | - | - | 1.685 | 407 | 1.386 | 1.768 | 1.787 | 1.777 |
| Inventories | - | - | - | - | 38 | 37 | 249 | 249 | 249 | 247 |
| Receivables | - | - | - | - | 42 | 41 | 40 | 41 | 40 | 40 |
| Cash | - | - | - | - | 1.605 | 329 | 1.097 | 1.478 | 1.498 | 1.489 |
| Shareholders Funds | - | - | - | - | 1.685 | -7.646 | -4.853 | -16.103 | 17.102 | 12.990 |
| Social Capital | - | - | - | - | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | 0 | 47.982 | 41.244 | 48.932 | 11.612 | 11.548 |
| Income in Advance | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "9602 - 9602" | |||||||||
| CAEN Financial Year |
9602
|
|||||||||
Comments - Epil Medica S.r.l.